CVS Health is a company in transition, moving away from the old pharmacy chain to an integrated healthcare giant. Read more ...

CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.

The vast majority of diagnoses codes that CVS subsidiary Coventry submitted to the CMS between 2018 and 2019 weren’t ...

Ariel Investments, an investment management company, released its “Ariel Global Fund” first-quarter 2025 investor letter. A ...

Investing.com -- CVS Health (NYSE: CVS) stock rose 1% on Wednesday after Bloomberg reported that Medicare Pharmacy Benefit Manager (PBM) limits were stripped from the Senate version of the tax bill.

Gone from this particular CVS are the groceries, greeting cards and gift items, replaced by a primary care practice with its 14 exam rooms, medical laboratory, large reception area and community room.

CVS Health is poised to benefit from the Senate’s latest tax bill revisions, which exclude proposed limits on Pharmacy Benefit Managers (PBMs) and cuts to Medicare Advantage programs.